Related Experiment Video
Updated: Mar 15, 2026

Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
The gut in the brain: the effects of bariatric surgery on alcohol consumption
Ashley N Blackburn1, Andras Hajnal2, Lorenzo Leggio1,3
1Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
Abstract:
Obesity represents a major medical and public health problem worldwide. Efforts have been made to develop novel treatments, and among them bariatric surgery is used as an effective treatment to achieve significant, long-term weight loss and alleviate medical problems related to obesity. Alcohol use disorder (AUD) is also a leading cause of morbidity and mortality worldwide. Recent clinical studies have revealed a concern for bariatric surgery patients developing an increased risk for alcohol consumption, and for AUD. A better understanding of the relationship between bariatric surgery and potential later development of AUD is important, given the critical need of identifying patients at high risk for AUD. This paper reviews current clinical and basic science research and discusses potential underlying mechanisms. Special emphasis in this review is given to recent work suggesting that, alterations in alcohol metabolism/pharmacokinetics resulting from bariatric surgery are unlikely to be the primary or at least the only explanation for increased alcohol use and development of AUD, as changes in brain reward processing are also likely to play an important role. Additional studies are needed to clarify the potential role and mechanisms of how bariatric surgery may increase alcohol use and lead to AUD development.
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Binge Eating Disorders
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

